VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 330 filers reported holding VALEANT PHARMACEUTICALS INTL in Q2 2017. The put-call ratio across all filers is 1.24 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2018 | $4,206,000 | +52.7% | 180,986 | +4.6% | 0.00% | – |
Q1 2018 | $2,754,000 | -13.4% | 173,004 | +13.0% | 0.00% | – |
Q4 2017 | $3,180,000 | +44.8% | 153,117 | -0.1% | 0.00% | – |
Q3 2017 | $2,196,000 | +47.9% | 153,307 | +78.7% | 0.00% | – |
Q2 2017 | $1,485,000 | +42.1% | 85,799 | -9.4% | 0.00% | – |
Q1 2017 | $1,045,000 | -40.9% | 94,736 | -22.2% | 0.00% | – |
Q4 2016 | $1,767,000 | -50.4% | 121,700 | -16.2% | 0.00% | – |
Q3 2016 | $3,566,000 | +9.6% | 145,265 | -10.1% | 0.00% | – |
Q2 2016 | $3,253,000 | -2.4% | 161,545 | +27.5% | 0.00% | – |
Q1 2016 | $3,332,000 | -69.0% | 126,698 | +19.9% | 0.00% | -100.0% |
Q4 2015 | $10,745,000 | -3.5% | 105,698 | +69.3% | 0.00% | 0.0% |
Q3 2015 | $11,137,000 | -34.7% | 62,429 | -18.7% | 0.00% | -50.0% |
Q2 2015 | $17,059,000 | -6.9% | 76,792 | -16.7% | 0.00% | 0.0% |
Q1 2015 | $18,318,000 | +37.5% | 92,227 | -1.0% | 0.00% | +100.0% |
Q4 2014 | $13,325,000 | -23.9% | 93,118 | -30.2% | 0.00% | -50.0% |
Q3 2014 | $17,508,000 | +113.8% | 133,445 | +105.6% | 0.00% | +100.0% |
Q2 2014 | $8,189,000 | -57.7% | 64,917 | -55.8% | 0.00% | -50.0% |
Q1 2014 | $19,364,000 | +220.9% | 146,876 | +104.9% | 0.00% | – |
Q4 2013 | $6,034,000 | -89.5% | 71,684 | -87.0% | 0.00% | -100.0% |
Q3 2013 | $57,726,000 | +2219.2% | 553,310 | +1813.9% | 0.01% | – |
Q2 2013 | $2,489,000 | – | 28,910 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Brave Warrior Advisors | 6,050,442 | $763,082,000 | 30.78% |
LeVasseur Capital Partners LLC | 190,404 | $24,014,000 | 29.50% |
FARLEY CAPITAL L.P. | 333,081 | $42,008,000 | 27.09% |
Ruane, Cunniff & Goldfarb | 34,298,384 | $4,325,712,000 | 23.07% |
ValueAct Holdings | 18,923,877 | $2,386,679,000 | 17.64% |
Tesuji Partners | 1,368,040 | $172,537,000 | 17.22% |
Brahman Capital Corp. | 3,902,877 | $492,231,000 | 13.63% |
Arrow Capital Management, LLC | 197,500 | $24,909,000 | 13.60% |
Hound Partners | 2,851,175 | $359,590,000 | 13.45% |
Ratan Capital Management LP | 731,960 | $92,315,000 | 13.09% |